Most of us have heard of procedures such as endoscopies and colonoscopies, which allow physicians to look inside the body to gather important information and make diagnoses. Dr. Dale Bredesen, a renowned physician and researcher in memory loss and neurodegenerative disease, coined the term cognoscopy.
Just as a colonoscopy can help detect colon cancer in its earliest stages, a cognoscopy can identify changes in the brain long before symptoms of memory loss appear. A cognoscopy combines laboratory testing, cognitive assessments, and advanced brain imaging to provide a comprehensive picture of brain health and function.
At The Memory Center, we utilize these tools to help identify memory, speech, and thinking disorders at their earliest stages. Because many of the changes that contribute to cognitive decline begin decades before symptoms develop, a cognoscopy can also be beneficial for healthy individuals—particularly those with a family history of dementia or risk factors such as chronic disease and inflammation. Early detection creates opportunities for earlier intervention and better long-term outcomes.
A cognoscopy begins with a comprehensive panel of blood tests. We evaluate genetic risk factors associated with dementia and measure a wide range of biomarkers that may reveal biological changes linked to memory, speech, and cognitive disorders. We also screen for chronic illnesses, chronic infections, and toxin exposure, all of which are known risk factors for cognitive decline and dementia.
The next step involves a series of cognitive assessments designed to evaluate memory, information processing, speech, and executive function. This includes objective questionnaires as well as advanced testing that measures and analyzes the brain’s electrical activity.
We also utilize several imaging technologies to evaluate both the brain and the blood vessels that support it. Ultrasound imaging allows us to assess the major arteries supplying blood to the brain, as narrowing or blockages can significantly reduce blood flow and contribute to cognitive decline. We also perform volumetric MRI scans, which provide detailed measurements of brain structures and can identify shrinkage and other abnormalities. In addition, specialized PET imaging may be used to detect amyloid plaque buildup, a hallmark feature of Alzheimer’s disease.
A cognoscopy is a simple yet highly comprehensive evaluation that provides remarkable insight into brain health. Whether you are concerned about your own memory or have a family history of cognitive disorders, we encourage you to learn more about this proactive approach to brain health.
Perhaps the most important benefit of a cognoscopy is its ability to identify changes in the brain years before symptoms develop. Since these changes often begin decades before noticeable memory problems occur, early action can have a profound impact on long-term health, independence, and quality of life.
We recommend a cognoscopy beginning at age 60 for all individuals, or at age 50 for those with a family history of memory disorders.
To learn more or schedule an appointment, call us at (201) 947-4777 or visit MemoryCenter.org.